The estimated Net Worth of Daniel Janney is at least $46.8 Millón dollars as of 8 June 2023. Mr. Janney owns over 50,000 units of Allakos Inc stock worth over $65,491 and over the last 21 years he sold ALLK stock worth over $46,303,733. In addition, he makes $463,260 as Independent Chair of the Board at Allakos Inc.
Daniel has made over 18 trades of the Allakos Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 50,000 units of ALLK stock worth $6,418,000 on 8 June 2023.
The largest trade he's ever made was buying 500,000 units of Allakos Inc stock on 17 March 2017 worth over $2,000,000. On average, Daniel trades about 47,467 units every 59 days since 2004. As of 8 June 2023 he still owns at least 107,362 units of Allakos Inc stock.
You can see the complete history of Mr. Janney stock trades at the bottom of the page.
Daniel S. Janney serves as Independent Chair of the Board of the Company. Mr. Janney is a managing director at Alta Partners, a life sciences venture capital firm, which he joined in 1996. Prior to joining Alta, from 1993 to 1996, Mr. Janney was a Vice President in Montgomery Securities’ healthcare and biotechnology investment banking group, focusing on life sciences companies. Mr. Janney is a director of a number of companies including Esperion Therapeutics, Krystal Biotech, Lassen Therapeutics and Prolacta Bioscience. Mr. Janney is currently a member of the executive committee of the California Academy of Sciences Board of Trustees. He holds a Bachelor of Arts in history from Georgetown University and an M.B.A. from the Anderson School at the University of California, Los Angeles.
As the Independent Chair of the Board of Allakos Inc, the total compensation of Daniel Janney at Allakos Inc is $463,260. There are 9 executives at Allakos Inc getting paid more, with Robert Alexander having the highest compensation of $12,559,300.
Daniel's mailing address filed with the SEC is C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203.
Over the last 6 years, insiders at Allakos Inc have traded over $246,100,922 worth of Allakos Inc stock and bought 5,181,222 units worth $35,384,176 . The most active insiders traders include Paul Edward Walker, Group, Llc Green Jeremy Red... y Daniel Janney. On average, Allakos Inc executives and independent directors trade stock every 43 days with the average trade being worth of $114,372. The most recent stock trade was executed by Harlan Baird Radford on 28 June 2024, trading 87,064 units of ALLK stock currently worth $87,935.
allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.
Allakos Inc executives and other stock owners filed with the SEC include: